Overall rank by patents
#28,930
Across all tracked assignees
USPTO PatentsView assignee record - 9 granted patents across 12 technology areas, active 2018–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61J (CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES ).
The verdict
HERO holds 9 US patents across 12 technology areas, rank #28,930 of 50,000 tracked assignees.
HERO Health Inc. has been granted 9 US utility patents between 2018 and 2025, placing HERO Health Inc. at rank #28,930 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.4 claims per patent with primary concentration in A61J (CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES ). As a US Corporation, HERO Health Inc. is one of the more focused assignees in the PatentsView dataset. By volume, HERO sits between Hedvig, Inc. (9 patents, rank #28,926) and HEYS International Ltd. (9 patents, rank #28,934) - the closest US assignees by grant volume. The composite Innovation Score of 31.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 7 grants, compared with 2 in the 2015–2019 window, a +250% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. HERO Health Inc.'s 14.4 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 12 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark HERO Health Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
HEDVIG, INC.
9 patents
HEFEI CAS ION MEDICAL AND TECHNICAL DEVICES CO., LTD.
9 patents
HEMLOCK SEMICONDUCTOR OPERATIONS LLC
9 patents
HENGDIAN GROUP INNUOVO ELECTRIC CO., LTD.
9 patents
HERO SCIENTIFIC LTD.
9 patents
HERON NEUTRON MEDICAL CORP.
9 patents
HEXAGON GEOSYSTEMS SERVICES AG
9 patents
HEYS INTERNATIONAL LTD.
9 patents
HERO HEALTH INC.
9 patents
What this shows HERO holds 9 patents at rank #28,930, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #28,930 in granted patent volume.
Other assignees with the most granted patents in HERO's primary technology class.
HERO's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
31 Top 63% higher than 37% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 2 | 22.2% |
| 2020 | 2 | 22.2% |
| 2021 | 1 | 11.1% |
| 2023 | 1 | 11.1% |
| 2025 | 3 | 33.3% |
Top 12 of 12 technology areas
Overall rank by patents
#28,930
Across all tracked assignees
31.1 out of 100
How to use this portfolio
HERO's 9 grants land it in the top 63% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.